Position in TRVI
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$46,709,167
+$2,420,558 QoQ
Shares Held
2,504,513
-32.5% QoQ
Ownership
1.76%
of shares outstanding
% of Portfolio
0.43%
of 13F equity value
Holder Rank
#16
of 216 holders
Holding Since
Jun 2022
17 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in TRVI Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Rubric Capital Management LP holds $1,431,610,576 across 20 Biotechnology names. TRVI ranks #11 (3.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ARQT |
Arcutis Biotherapeutics, Inc.
|
8,271,577 | $216,880,748 | |
| 2 | ROIV |
Roivant Sciences Ltd.
|
6,000,000 | $212,340,000 | |
| 3 | ZYME |
Zymeworks Inc.
|
7,000,000 | $182,980,000 | |
| 4 | NRIX |
Nurix Therapeutics, Inc.
|
7,227,778 | $175,345,894 | |
| 5 | MGTX |
MeiraGTx Holdings plc
|
9,100,000 | $122,941,000 | |
| 6 | ARDX |
Ardelyx, Inc.
|
16,202,700 | $82,633,770 | |
| 7 | ADMA |
Adma Biologics, Inc.
|
9,339,414 | $78,170,895 | |
| 8 | MNKD |
Mannkind Corp
|
18,000,000 | $76,680,000 |
All Filings in TRVI
Export CSV
18 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $46,709,167 | 2,504,513 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $44,288,609 | 3,712,373 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $47,159,697 | 3,766,749 | Shares | Sole | 2026-02-13 | |
| 2025-12-31 | $47,159,697 | 3,766,749 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $78,066,519 | 8,531,860 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $46,669,274 | 8,531,860 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $28,547,385 | 4,538,535 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $17,325,131 | 4,205,129 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $16,789,949 | 5,026,931 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $14,980,254 | 5,026,931 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $19,196,224 | 5,564,123 | Shares | Sole | 2024-05-10 | |
| 2023-12-31 | $7,617,122 | 5,684,420 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $12,392,035 | 5,684,420 | Shares | Sole | 2023-11-15 | |
| 2023-06-30 | $13,585,763 | 5,684,420 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $10,516,177 | 5,684,420 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $10,970,930 | 5,684,420 | Shares | Sole | 2023-02-10 | |
| 2022-09-30 | $8,754,006 | 5,684,420 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $4,997,360 | 1,778,420 | Shares | Sole | 2022-08-15 | |
| No filing history on record for this holder in this stock. | ||||||